Skip to main navigation

Back to SpringWorksTx.com
Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

29 Sep 2022

SpringWorks Therapeutics Announces Dosing of First Patient in Phase 2 Trial Evaluating Nirogacestat in Patients with Ovarian Granulosa Cell Tumors

PDF Version

10 Sep 2022

SpringWorks Therapeutics Announces Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2022

PDF Version

07 Sep 2022

SpringWorks Therapeutics Announces $225 Million Private Placement Financing

PDF Version

07 Sep 2022

SpringWorks Announces Expansion of Global, Non-Exclusive Collaboration with GSK for Nirogacestat in Combination with Blenrep in Patients with Multiple Myeloma

PDF Version

19 Aug 2022

SpringWorks Therapeutics Announces Late-Breaking Oral Presentation of Phase 3 DeFi Data at the European Society for Medical Oncology (ESMO) Congress 2022

PDF Version

04 Aug 2022

SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights

PDF Version

02 Aug 2022

SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference

PDF Version

15 Jul 2022

SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors

PDF Version

10 Jun 2022

SpringWorks Therapeutics to Present Progress Across the Company’s Targeted Oncology Portfolio at Virtual R&D Day

PDF Version

09 Jun 2022

SpringWorks Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 102

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Footer 1

Who We Are
Focus Areas

Footer 2

Pipeline
Careers
- View Opportunities
- Desmoid Tumor Commercial Team

Footer 3

Patients
Contact

Footer 4

Investors & Media

© 2022 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use
Cookie Policy